WHY ATTEND

500+ Attendees
300+ Companies
85% Decision Makers
200+ Speakers
6 Conference Tracks

 

 

THE STRONGEST AGENDA YET

Governed by our Scientific Advisory Board, which includes: 13 leading pioneers of the vaccine & immunotherapy industry that have ensured the agenda, topics and speakers are relevant and cutting edge, so that your 3 days with us will be the most memorable yet.

 

INTERNATIONAL DECISON MAKERS

Hear from over 200+ senior speakers across the from the WHO, CEPI, European Commission, EMA, FDA in government to C-level executives from GSK, Merck, Pfizer, Janssen, Sanofi and innovative biotechs. We expect over 600 attendees. This is your best chance of the year to meet and network with hundreds of like-minded peers at USA’s most exciting vaccine & immunotherapy congress.

 

NEW WORKSHOPS AND CONFERENCE TRACKS

Attend focused sessions across multiple tracks. Take this unique opportunity to gain valuable insight into the vaccine industry.

Immune Profiling
Cancer Immunotherapy
Vaccine Development
Delivery Bioprocessing and Manufacture
New Technology
Pre-Clinical and Clinical Development

 

NETWORKING

There are more networking opportunities, with three days’ worth of content, pre- conference workshops, extended breaks and multiple drinks receptions, so you will have even more time to meet cross sector contacts with over 500+ attendees.

 

 

WHO ATTENDS

 

TITLES

CEO / CSO / COO/ HEAD OF

 

Scientific Affairs
Influenza
Infectious Disease
R&D
Regulatory Affairs
Manufacturing
Immunology
Immuno-Oncology
Vaccines
Clinical Development
Procurement
Protein Discovery
Protein Engineering
Translational Medicine /Science
Analytical Development
Technical Operations
Biomarkers
(Bio)informatics
Precision Medicine

 

 

sectors